Médica Sur. de Valuation
Is MEDICA B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MEDICA B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MEDICA B (MX$30.35) is trading below our estimate of fair value (MX$83.16)
Significantly Below Fair Value: MEDICA B is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MEDICA B?
Key metric: As MEDICA B is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is MEDICA B's PE Ratio? | |
|---|---|
| PE Ratio | 8.8x |
| Earnings | Mex$371.84m |
| Market Cap | Mex$3.27b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.8x |
| Enterprise Value/EBITDA | 5x |
| PEG Ratio | 0.7x |
Price to Earnings Ratio vs Peers
How does MEDICA B's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 23.1x | ||
EKH Ekachai Medical Care | 15.8x | 2.1% | ฿5.0b |
9906 Honliv Healthcare Management Group | 32.6x | n/a | HK$1.2b |
HUM Humana | 15.2x | 44.7% | SEK 1.9b |
GPTHEALTH GPT Healthcare | 28.7x | 20.1% | ₹13.7b |
MEDICA B Médica Sur. de | 8.8x | 11.9% | Mex$3.3b |
Price-To-Earnings vs Peers: MEDICA B is good value based on its Price-To-Earnings Ratio (8.8x) compared to the peer average (23.1x).
Price to Earnings Ratio vs Industry
How does MEDICA B's PE Ratio compare vs other companies in the Global Healthcare Industry?
| 11 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 11 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: MEDICA B is good value based on its Price-To-Earnings Ratio (8.8x) compared to the Global Healthcare industry average (20.6x).
Price to Earnings Ratio vs Fair Ratio
What is MEDICA B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 8.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MEDICA B's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
AMN Healthcare Services
US$2.2b
Provides healthcare workforce solutions and staffing services to healthcare facilities in the United States.
AMN *
US$1,293.00
7D
0%
1Y
-17.6%
Teladoc Health
US$1.5b
Provides virtual healthcare services worldwide.
TDOC *
US$210.00
7D
12.9%
1Y
-27.9%
ZimVie
US$186.2m
Develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.
ZIMV *
US$230.00
7D
0%
1Y
n/a